| Literature DB >> 35407254 |
Anuoluwapo Anele1, Sherine Obare1,2, Jianjun Wei1.
Abstract
Antibiotic resistance is a formidable global threat. Wastewater is a contributing factor to the prevalence of antibiotic-resistant bacteria and genes in the environment. There is increased interest evident from research trends in exploring nanoparticles for the remediation of antibiotic-resistant bacteria. Cobalt oxide (Co3O4) nanoparticles have various technological, biomedical, and environmental applications. Beyond the environmental remediation applications of degradation or adsorption of dyes and organic pollutants, there is emerging research interest in the environmental remediation potential of Co3O4 nanoparticles and its nanocomposites on antibiotic-resistant and/or pathogenic bacteria. This review focuses on the recent trends and advances in remediation using Co3O4 nanoparticles and its nanocomposites on antibiotic-resistant or pathogenic bacteria from wastewater. Additionally, challenges and future directions that need to be addressed are discussed.Entities:
Keywords: anti-bacterial agents; antibacterial mechanism; antibiotic resistance; antibiotics; bacteria; cobalt oxide nanoparticles; drug resistance; environment; remediation; wastewater
Year: 2022 PMID: 35407254 PMCID: PMC9000771 DOI: 10.3390/nano12071129
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Figure 1Overview of synthesis methods for cobalt oxide (Co3O4) nanoparticles. Physicochemical methods such as laser ablation [32,33], laser fragmentation [34], casting technique [35], precipitation [36,37], microemulsion quenching technique [38], and microwave irradiation [36,39] have been used for synthesis. Biological methods based on plants [1,7], biological molecules [40,41], and microbes [3] have also been applied in the synthesis of Co3O4 nanoparticles.
Cobalt oxide nanoparticle synthesis, characterization, and characteristics.
| Material | Synthesis Method | Characterization Method | Morphology | Size | Reference |
|---|---|---|---|---|---|
| Co3O4 | Biological (plant extract) synthesis and hot plate combustion method | XRD, FTIR, Raman, HRTEM, EDS, and UV-Vis | Quasi-spherical shape and high agglomeration | 1–7 nm | [ |
| Co3O4 | Biological (myco-) synthesis | DLS, EDS, FTIR, VSM, FESEM, HRTEM | Quasi-spherical shape and monodispersed | 20–27 nm | [ |
| Co3O4 | Biological (plant extract) synthesis | TEM, SEM, XRD, FTIR | Square-shaped, and aggregated | 15–35 nm | [ |
| Co3O4 | Biological molecule-based synthesis | FTIR, XRD, SEM, TGA | Mixture of octahedron, tetrahedron, spheroidal, flakelike morphologies | 20 nm–2 µm | [ |
| Co3O4 | Biological molecule-based synthesis | AFM, XPS | Spherical | 2.5–3 nm | [ |
| Co3O4 | Microwave synthesis and calcination | XRD, UV, FTIR, HRSEM, PL, TEM | Spherical and agglomerated | 13 nm | [ |
| Co3O4 | Precipitation and calcination | FTIR, SEM, TEM, XRD, UV-Vis | Spherical, interconnected, layered structure | 32.66 nm | [ |
| Co3O4 | Microwave synthesis and calcination | FTIR, SEM, TEM, XRD, UV-Vis | Spherical, interconnected, layered structure | 72.43 nm | [ |
| Co3O4 | Casting technique and calcination | XRD, TEM, IR, UV-Vis | Cubic, no agglomeration | 13 nm | [ |
| Co3O4 | Microemulsion quenching technique | TEM, FESEM, EDS, XRD, UV-Vis | Spherical | 1–5 nm | [ |
| Co3O4 | Laser ablation | UV-Vis-NIR, TEM, SEM, XRD, FTIR, PL, DLS, VSM | Spherical with some agglomeration | 10 nm | [ |
| Co3O4 | Laser ablation | TEM, Raman, UV-Vis, XPS, CV | Spherical, agglomerated | ∼2.5 nm | [ |
| Co3O4 | Laser fragmentation | XRD, TEM, EDS, XPS, Raman, FTIR | Uniform, spherical, well dispersed | ∼5.8 nm | [ |
Figure 2Electron microscopy and UV-Vis images of select nanoparticles. (A) Range of sizes of select Co3O4 nanoparticles and their nanocomposites: (i) transmission electron microscope micrograph of Co/Co3O4 nanocomposites synthesized according to the sonochemical method (∼20 nm in size). This image was adapted from Yousefi et al. [51] with permission from Elsevier. (ii) Transmission electron microscope micrograph of α-Fe2O3/Co3O4 nanocomposites synthesized via the co-precipitation method (average crystallite size of 25.34 nm). This image was adapted from Bhushan et al. [50] under the open access Creative Common CC BY license of Springer Nature. (iii) High-resolution transmission electron microscope image of myco-synthesized Co3O4 nanoparticles (20–27 nm in size). This figure was adapted from Omran et al. [3] with permission from John Wiley and Sons. (iv) Transmission electron microscope image of plant extract-synthesized Co3O4 nanoparticles (size 15–35 nm). This image was adapted from Hafeez et al. [7] under the open access Creative Common CC BY license of IOPScience. (B) Morphology and spectra of select Co3O4 nanoparticles used in antibacterial applications: (i) field scanning electron microscope micrograph of myco-synthesized Co3O4 nanoparticles showing their spherical-like morphology. (ii) UV/Vis absorption spectrum of myco-synthesized Co3O4 nanoparticles showing a distinct absorption peak at λ280nm. These images were adapted from Omran et al. [3] with permission from John Wiley and Sons. (iii,iv) High-resolution scanning electron microscope micrographs of spherical, agglomerated Co3O4 nanoparticles. (v) UV/Vis/NIR absorption spectrum of Co3O4 nanoparticles showing an absorption peak at λ208nm. These images were adapted from Mayakannan et al. [39] with permission from Elsevier.
Synthesis, characterization, and characteristics of cobalt oxide nanocomposites.
| Material | Synthesis Method | Characterization Method | Morphology | Size | Reference |
|---|---|---|---|---|---|
| α-Fe2O3-Co3O4 | Co-precipitation and calcination | XRD, TEM, EDS, VSM, | Mixture of rod-shaped and hexagonal | 25.34 nm (crystallite size) | [ |
| Ni doped-Co3O4 | Microwave synthesis and annealing | XRD, UV-Vis-NIR, FTIR, HRSEM, | Nanocubes | 15–41 nm | [ |
| Co/Co3O4 | Sonochemical method | SEM, FTIR, XRD, VSM, EDS, | Snowballs | ∼20 nm | [ |
| MnFe2O4-Co3O4 | Sonochemical co-precipitation method | HRTEM, EDS, XRD, PL, DRS, VSM, FTIR | MnFe2O4 nanorods attached to Co3O4 nanostructures | Not indicated | [ |
| polyhydroxybutyrate-Co3O4 | Co-precipitation method | FTIR, UV-Vis, XRD, SEM, EDS, TEM, TGA, DTA | Uneven surfaced structure, agglomerated; well dispersed Co3O4 in biopolymer | Not indicated | [ |
| Co3O4@ZrO2 | Sol-gel method | UV-Vis, FTIR, CV, FESEM, XRD | Spherical with irregular morphology; agglomerated | 378.8 nm and 681.4 nm | [ |
Figure 3Mechanism of antibiotic resistance in antibiotic-resistant bacteria. Antibiotic-resistant bacteria may neutralize antibiotics via different mechanisms such as inactivating enzymes, altering their permeability to reduce antibiotics taken into the cell, eliminating antibiotics that enter the cell using efflux pumps, decreasing uptake of antibiotics, and modifying the targets of the antibiotics. Bacteria may acquire these resistance mechanisms via transduction, conjugation, mutation, and transformation. Reprinted from Álvarez-Martínez et al. [61] under the open access Creative Common CC BY license of MDPI.
Figure 4Graphic representation showing: (a) cell wall structures of gram-positive and gram-negative bacteria. (b) Antibacterial mechanism of nanoparticles. (A) Cell membrane is disrupted, leading to cell leakage. (B) Nanoparticles can bind to cellular components. (C) Electron transport is disrupted, thereby leading to electrolyte imbalance. (D) Reactive oxygen species are generated. Reproduced from Gupta et al. [74] with permission from the Royal Society of Chemistry.
Figure 5Graphic representation showing the antimicrobial mechanisms of metal oxide nanoparticles. Reproduced from Raghunath and Perumal [44] with permission from Elsevier.
Cobalt oxide nanoparticles and bacteria remediation capability.
| Target Bacteria in Study | Method of Assessing | Concentration Used | Contact Time and | Antibacterial/Inhibitory | Summary of Mechanism of Antibacterial/Inhibitory | Reference |
|---|---|---|---|---|---|---|
|
| Disc diffusion method | 0.001 g/10 mL | Incubated at 37 °C for 24 h | 18.6 mm zone of inhibition | Probably cell membrane disruption and oxidative stress from ROS | [ |
|
| Disc diffusion method | 0.001 g/10 mL | Incubated at 37 °C for 24 h | 20.8 mm zone of inhibition | Probably cell membrane disruption and oxidative stress from ROS | |
|
| Disc diffusion method | 0.001 g/10 mL | Incubated at 37 °C for 24 h | 18.5 mm zone of inhibition | Probably cell membrane disruption and oxidative stress from ROS | |
|
| Disc diffusion method | 0.001 g/10 mL | Incubated at 37 °C for 24 h | 25.1 mm zone of inhibition | Probably cell membrane disruption and oxidative stress from ROS | |
|
| Disc diffusion method | 0.001 g/10 mL | Incubated at 37 °C for 24 h | 16.3 mm zone of inhibition | Probably cell membrane disruption and oxidative stress from ROS | [ |
|
| Disc diffusion method | 0.001 g/10 mL | Incubated at 37 °C for 24 h | 22.2 mm zone of inhibition | Probably cell membrane disruption and oxidative stress from ROS | |
|
| Disc diffusion method | 0.001 g/10 mL | Incubated at 37 °C for 24 h | 34.5 mm zone of inhibition | Probably cell membrane disruption and oxidative stress from ROS | |
|
| Disc diffusion method | 0.001 g/10 mL | Incubated at 37 °C for 24 h | 16.4 mm zone of inhibition | Probably cell membrane disruption and oxidative stress from ROS | |
| Agar plate well diffusion method | 5 mg mL−1 | Not indicated | 15.6 mm zone of inhibition | Attributed to size effects | [ | |
| Agar plate well diffusion method | 5 mg mL−1 | Not indicated | 20 mm zone of inhibition | Attributed to size effects | ||
| Agar plate well diffusion method | 5 mg mL−1 | Not indicated | 11.3 mm zone of inhibition | Attributed to size effects | ||
| Agar plate well diffusion method | 5 mg mL−1 | Not indicated | 12 mm zone of inhibition | Attributed to size effects | ||
| MIC and MLC | 0.035–5 mg mL−1 | Optical density (OD600) taken after incubation at 24 h | 2.5 mg mL−1 | Attributed to size effects | [ | |
| MIC and MLC | 0.035–5 mg mL−1 | Optical density (OD600) taken after incubation at 24 h | 5 mg mL−1 | Attributed to size effects | ||
| MIC and MLC | 0.035–5 mg mL−1 | Optical density (OD600) taken after incubation at 24 h | 2.5 mg mL−1 | Attributed to size effects | ||
| MIC and MLC | 0.035–5 mg mL−1 | Optical density (OD600) taken after incubation at 24 h | 2.5 mg mL−1 | Attributed to size effects | ||
|
| Agar plate well diffusion method | 2, 4, and 8 mg mL−1 | Incubated at 37 °C for 24 h | 23.5 mm zone of inhibition at a dose of 8 mg mL−1 | Attributed to size effects and ROS damage to bacteria DNA, protein, and cell membrane | [ |
|
| Agar plate well diffusion method | 2, 4, and 8 mg mL−1 | Incubated at 37 °C for 24 h | 27.2 mm zone of inhibition at a dose of 8 mg mL−1 | Attributed to size effects and ROS damage to bacteria DNA, protein, and cell membrane | |
|
| Agar plate well diffusion method | 2, 4, and 8 mg mL−1 | Incubated at 37 °C for 24 h | 25.3 mm zone of inhibition at a dose of 8 mg mL−1 | Attributed to size effects and ROS damage to bacteria DNA, protein, and cell membrane | |
|
| Agar plate well diffusion method | 8 mg mL−1 | Incubated at 37 °C for 24 h | 24.2 mm zone of inhibition at a dose of 8 mg mL−1 | Attributed to size effects and ROS damage to bacteria DNA, protein, and cell membrane | |
|
| Disc diffusion method | 31.25–500 µg/mL | Incubated at 37 °C for 24 h | 22.8 mm zone of inhibition at a dose of 500 µg/mL | Attributed to size effects and ROS effects on cellular contents | [ |
|
| Disc diffusion method | 31.25–500 µg/mL | Incubated at 37 °C for 24 h | 28.4 mm zone of inhibition at a dose of 500 µg/mL | Attributed to size effects and ROS effects on cellular contents | |
|
| Disc diffusion method | 31.25–500 µg/mL | Incubated at 37 °C for 24 h | 29.2 mm zone of inhibition at a dose of 500 µg/mL | Attributed to size effects and ROS effects on cellular contents |
Figure 6Graphic representation showing the antibacterial mechanisms of cobalt oxide nanoparticles: (a) formation of OH after light irradiation of nanoparticles. (b) Inhibition of bacterial growth after exposure to nanoparticles. Reproduced from Sivachidambaram et al. [76] with permission from the Royal Society of Chemistry under the open access Creative Common CC BY license of RSC Advances.
Cobalt oxide nanocomposites or other cobalt oxide based nanoparticles and bacteria remediation capability.
| Material Used in Study | Target Bacteria in Study | Method of Assessing | Concentration Used | Contact Time and Other Conditions | Antibacterial/Inhibitory | Summary of Mechanism of Antibacterial/Inhibitory | Reference |
|---|---|---|---|---|---|---|---|
| α-Fe2O3/Co3O4 |
| Disc diffusion method | 400, 600 and 800 µg | Incubated at 37 °C for 24 h | 21 mm zone of inhibition at a dose of 800 µg | Attributed to ROS effects on cellular contents | [ |
|
| 24 mm zone of inhibition at a dose of 800 µg | ||||||
|
| 26 mm zone of inhibition at a dose of 800 µg | ||||||
|
| 19 mm zone of inhibition at a dose of 800 µg | ||||||
| α-Fe2O3/Co3O4 |
| Growth curve analysis | 45, 60, 75, 90 and 120 mg/dL | Incubated at 37 °C for 24 h (reading taken at 6 h intervals) | OD600 = ∼0.3 at a concentration of 120 mg/dL after 24 h; MIC = 90 mg/dL | Attributed to ROS effects on cellular contents | [ |
|
| OD600 = 0 at a concentration of 120 mg/dL after 24 h; MIC = 75 mg/dL | ||||||
|
| OD600 = 0 at a concentration of 120 mg/dL after 24 h; MIC = 45 mg/dL | ||||||
|
| OD600 = ∼0.01 at a concentration of 120 mg/dL after 24 h; MIC = 60 mg/dL | ||||||
| β-CoMoO4-Co3O4 |
| Agar plate well diffusion method | 1.56–50 mg/mL | Incubated at 37 °C for 24 h | 17 mm zone of inhibition at a dose of 50 mg/mL | Electrostatic interactions with bacteria and ROS effects | [ |
|
| 19 mm zone of inhibition at a dose of 50 mg/mL | ||||||
|
| 18 mm zone of inhibition at a dose of 50 mg/mL | ||||||
| Co/Co3O4 |
| MIC and MBC | ∼0–2000 µg/mL | CLSI guidelines | MIC = ∼125 µg/mL | Not indicated | [ |
|
| MIC = ∼500 µg/mL | ||||||
|
| MIC = 31.25 µg/mL | ||||||
|
| MIC = ∼500 µg/mL | ||||||
|
| MIC = ∼500 µg/mL | ||||||
| Ni doped-Co3O4 | Agar plate well diffusion method | 100 µg/mL | Incubated at 37 °C for 24 h | 20 mm zone of inhibition | Attributed to interactions of nanoparticle with bacteria cell membrane | [ | |
| 14 mm zone of inhibition | |||||||
| 18 mm zone of inhibition | |||||||
| 13 mm zone of inhibition | |||||||
| Co3O4@ZrO2 |
| Agar plate well diffusion method | 50, 100 and 200 µg/mL | Incubated at 37 °C for 24 h | ∼˂1 mm zone of inhibition at a dose of 200 µg/mL | Attributed to cell wall penetration and genotoxicity resulting in cell deformation | [ |
|
| ∼13 mm zone of inhibition at a dose of 200 µg/mL | ||||||
|
| ∼1 mm zone of inhibition at a dose of 200 µg/mL | ||||||
|
| ∼12 mm zone of inhibition at a dose of 200 µg/m |